Newman Dignan & Sheerar Inc’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.75M | Sell |
7,582
-43
| -0.6% | -$14.7K | 0.53% | 48 |
|
|
2026
Q1 | $2.68M | Sell |
7,625
-198
| -3% | -$70.6K | 0.56% | 43 |
|
|
2025
Q4 | $2.56M | Buy |
7,823
+176
| +2% | +$55.8K | 0.53% | 46 |
|
|
2025
Q3 | $2.16M | Sell |
7,647
-408
| -5% | -$118K | 0.47% | 53 |
|
|
2025
Q2 | $2.25M | Sell |
8,055
-30
| -0.4% | -$8.5K | 0.52% | 49 |
|
|
2025
Q1 | $2.52M | Buy |
8,085
+81
| +1% | +$23.9K | 0.69% | 40 |
|
|
2024
Q4 | $2.09M | Sell |
8,004
-159
| -2% | -$47.2K | 0.53% | 49 |
|
|
2024
Q3 | $2.59M | Sell |
8,163
-30
| -0.4% | -$9.81K | 0.62% | 45 |
|
|
2024
Q2 | $2.56M | Sell |
8,193
-689
| -8% | -$202K | 0.66% | 41 |
|
|
2024
Q1 | $2.53M | Sell |
8,882
-513
| -5% | -$150K | 0.68% | 41 |
|
|
2023
Q4 | $2.71M | Sell |
9,395
-79
| -0.8% | -$21.5K | 0.82% | 37 |
|
|
2023
Q3 | $2.55M | Sell |
9,474
-267
| -3% | -$66.6K | 0.84% | 37 |
|
|
2023
Q2 | $2.16M | Sell |
9,741
-57
| -0.6% | -$13.2K | 0.67% | 43 |
|
|
2023
Q1 | $2.37M | Sell |
9,798
-151
| -2% | -$37.1K | 0.76% | 37 |
|
|
2022
Q4 | $2.61M | Buy |
9,949
+2
| +0% | +$536 | 0.87% | 37 |
|
|
2022
Q3 | $2.24K | Sell |
9,947
-35
| -0.4% | -$8.48K | 0.35% | 37 |
|
|
2022
Q2 | $2.43M | Buy |
9,982
+69
| +0.7% | +$16.9K | 0.83% | 35 |
|
|
2022
Q1 | $2.4K | Buy |
9,913
+12
| +0.1% | +$2.76K | 0.46% | 39 |
|
|
2021
Q4 | $2.23M | Sell |
9,901
-66
| -0.7% | -$13.9K | 0.68% | 41 |
|
|
2021
Q3 | $2.12M | Buy |
9,967
+1
| +0% | +$230 | 0.61% | 38 |
|
|
2021
Q2 | $2.43M | Sell |
9,966
-119
| -1% | -$29.3K | 0.82% | 31 |
|
|
2021
Q1 | $2.51M | Sell |
10,085
-535
| -5% | -$128K | 0.91% | 32 |
|
|
2020
Q4 | $2.44K | Sell |
10,620
-98
| -0.9% | -$22.6K | 0.39% | 33 |
|
|
2020
Q3 | $2.72M | Sell |
10,718
-19
| -0.2% | -$4.71K | 1.14% | 23 |
|
|
2020
Q2 | $2.64M | Buy |
10,737
+135
| +1% | +$30.8K | 1.14% | 24 |
|
|
2020
Q1 | $2.35M | Sell |
10,602
-108
| -1% | -$23.6K | 1.23% | 20 |
|
|
2019
Q4 | $2.58K | Sell |
10,710
-86
| -0.8% | -$19K | 0.28% | 27 |
|
|
2019
Q3 | $2.09M | Buy |
10,796
+80
| +0.7% | +$15.4K | 0.98% | 28 |
|
|
2019
Q2 | $1.98K | Sell |
10,716
-265
| -2% | -$47.5K | 0.05% | 28 |
|
|
2019
Q1 | $2.09M | Sell |
10,981
-247
| -2% | -$47.2K | 0.84% | 29 |
|
|
2018
Q4 | $2.19K | Buy |
11,228
+510
| +5% | +$99.5K | 0.19% | 31 |
|
|
2018
Q3 | $2.19M | Buy |
10,718
+136
| +1% | +$26.8K | 0.96% | 28 |
|
|
2018
Q2 | $1.95K | Buy |
10,582
+212
| +2% | +$37.5K | 0.13% | 27 |
|
|
2018
Q1 | $1.78M | Sell |
10,370
-601
| -5% | -$110K | 0.9% | 28 |
|
|
2017
Q4 | $1.91M | Sell |
10,971
-115
| -1% | -$20.4K | 0.95% | 27 |
|
|
2017
Q3 | $2.07M | Sell |
11,086
-149
| -1% | -$26.4K | 1.1% | 24 |
|
|
2017
Q2 | $1.94M | Buy |
11,235
+185
| +2% | +$30.1K | 1.07% | 24 |
|
|
2017
Q1 | $1.81K | Sell |
11,050
-5
| -0% | -$831 | 0.8% | 31 |
|
|
2016
Q4 | $1.62M | Sell |
11,055
-175
| -2% | -$26.3K | 0.99% | 29 |
|
|
2016
Q3 | $1.87M | Buy |
11,230
+201
| +2% | +$34K | 1.18% | 23 |
|
|
2016
Q2 | $1.68M | Buy |
11,029
+195
| +2% | +$30.3K | 1.05% | 26 |
|
|
2016
Q1 | $1.62M | Buy |
10,834
+156
| +1% | +$23.2K | 1.18% | 23 |
|
|
2015
Q4 | $1.73M | Buy |
10,678
+83
| +0.8% | +$13K | 1.22% | 24 |
|
|
2015
Q3 | $1.47M | Buy |
10,595
+51
| +0.5% | +$8.04K | 0.94% | 25 |
|
|
2015
Q2 | $1.62M | Sell |
10,544
-93,453
| -90% | -$15M | 1.17% | 23 |
|
|
2015
Q1 | $1.66M | Buy |
103,997
+93,618
| +902% | +$14.7M | 1.19% | 21 |
|
|
2014
Q4 | $1.65K | Sell |
10,379
-93,403
| -90% | -$14.6M | 0.99% | 26 |
|
|
2014
Q3 | $1.46M | Buy |
103,782
+93,374
| +897% | +$12.2M | 1.1% | 25 |
|
|
2014
Q2 | $1.23K | Buy |
10,408
+1,200
| +13% | +$139K | 0.7% | 38 |
|
|
2014
Q1 | $1.14M | Buy |
9,208
+2,678
| +41% | +$325K | 0.81% | 39 |
|
|
2013
Q4 | $745 | Buy |
6,530
+2,395
| +58% | +$272K | 0.04% | 63 |
|
|
2013
Q3 | $463K | Buy |
4,135
+403
| +11% | +$43.7K | 0.36% | 87 |
|
|
2013
Q2 | $368 | Buy |
+3,732
| New | +$387K | 0.03% | 94 |
|
Other funds holding AMGN
FFM
Newman Dignan & Sheerar Inc's AMGN Position: Q2 2026 in Review
Newman Dignan & Sheerar Inc reduced its Amgen (AMGN) stake by 0.56% in Q2 2026, selling an estimated $14.7K and leaving 7,582 shares worth $2.75M. The position accounts for 0.53% of the portfolio, ranked #48.
Newman Dignan & Sheerar Inc first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Newman Dignan & Sheerar Inc held 7,582 shares of Amgen worth $2.75M as of Q2 2026.
- Newman Dignan & Sheerar Inc sold 43 Amgen shares in Q2 2026, an estimated $14.7K.
- Amgen made up 0.53% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #48 holding.
- Newman Dignan & Sheerar Inc first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.